![Michael Egholm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Egholm
Verkställande Direktör på
STANDARD BIOTOOLS INC.
Förmögenhet: 5 M $ per 2026-06-30
Profil
Michael Egholm was the founder of Danaher Corp., founded in 2017, where the title held was Chief Technology Officer-Danaher Life Sciences from 2017 to 2021.
Current jobs include President, Chief Executive Officer & Director at Standard BioTools, Inc. since 2021; Director at Abbratech, Inc.; and Member at the Royal Danish Academy of Sciences & Letters.
Former jobs include President, CEO, Secretary, Treasurer & Director at SomaLogic, Inc.; Independent Director at IsoPlexis Corp.
from 2018 to 2022; President-Biopharmaceuticals at Pall Corp.
from 2014 to 2017; Vice President-Research at Molecular Staging, Inc.; Chief Technology Officer at Roche Applied Science from 2008 to 2010; and Chief Technology Officer at 454 Life Sciences Corp.
from 2004 to 2010.
Education includes a doctorate from the University of Copenhagen.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-03 | 6 235 331 ( 1,6 % ) | 5 M $ | 2026-06-30 |
Aktiva positioner av Michael Egholm
| Företag | Position | Start |
|---|---|---|
| STANDARD BIOTOOLS INC. | Verkställande Direktör | 2021-10-01 |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Direktör/Styrelseledamot | - |
Royal Danish Academy of Sciences & Letters | Företagsledare/Principal | - |
Tidigare kända positioner av Michael Egholm
| Företag | Position | Slut |
|---|---|---|
| ISOPLEXIS CORPORATION | Direktör/Styrelseledamot | 2022-08-22 |
| DANAHER CORPORATION | Grundare | 2021-09-01 |
| PALL CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | 2014-09-10 |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Teknisk/Vetenskaplig/F&U Direktör | 2010-06-01 |
Roche Applied Science
 Roche Applied Science Miscellaneous Commercial ServicesCommercial Services Engages in researching molecular diagnostics | Teknisk/Vetenskaplig/F&U Direktör | 2010-01-01 |
Michael Egholms utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
63
Första gradens relationer
11
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Danaher Corp.
 Danaher Corp. Medical SpecialtiesHealth Technology Provides life sciences and diagnostic services | Health Technology |
Pall Corp.
 Pall Corp. Industrial MachineryProducer Manufacturing Designs, manufactures and markets filtration & separation equipment | Producer Manufacturing |
Standard BioTools, Inc.
 Standard BioTools, Inc. Medical SpecialtiesHealth Technology Manufactures and markets innovative technologies and tools for life sciences research | Health Technology |
IsoPlexis Corp.
 IsoPlexis Corp. Medical SpecialtiesHealth Technology Develops single cell multiplexing immunoassay systems | Health Technology |
Molecular Staging, Inc.
 Molecular Staging, Inc. Medical SpecialtiesHealth Technology Develops products for the detection & measurement of proteins and nucleic acids | Health Technology |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Applied Science
Roche Applied Science Miscellaneous Commercial ServicesCommercial Services Engages in researching molecular diagnostics | Commercial Services |
Royal Danish Academy of Sciences & Letters | |
SomaLogic, Inc.
 SomaLogic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a protein biomarker discovery and clinical diagnostics company | Commercial Services |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Health Technology |
